Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

BKK/TMAN stock hub

BKK/TMAN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BKK/TMANis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

4.7B

Stock Exchange of Thailand

Market data

Live price

Current market quote for this ticker.

Current price

BKK/TMAN

In the news

Latest news · BKK/TMAN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E9.4

P25 12.7P50 15.3P75 17.3

Trailing P/E9

P25 11P50 14.1P75 19.7

ROE26.9

P25 5.8P50 9.6P75 13.9

ROIC21.9

P25 4.4P50 10.5P75 16.6

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BKK/TMAN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

203

Groups with data

Currency

THB

Showing 203 of 203 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Thailand
Country code	TH
Employees	944
Employees Change	115%
Employees Change Percent	16.22
Enterprise value	THB 4.9B
Exchange	Stock Exchange of Thailand
Financial currency	THB
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Last refreshed	2026-05-10
Market cap	THB 4.7B
Price	THB 11.8
Price currency	THB
Rev Per Employee	2,675,917.28x
Sector	Healthcare
Sic	2834
Symbol	bkk/TMAN
Website	https://www.tmanpharmaceutical.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	11.08%
EV Earnings	9.39x
EV/EBIT	8.4x
EV/EBITDA	6.91x
EV/FCF	44.65x
EV/Sales	1.94x
FCF yield	2.33%
Forward P/E	9.37x
P/B ratio	2.23x
P/E ratio	9.02x
P/S ratio	1.87x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	23.15%
EBITDA Margin	27.74%
FCF margin	4.35%
Gross margin	47.02%
Gross Profit	THB 1.2B
Gross Profit Growth	8.64%
Gross Profit Growth Q	14.8%
Gross Profit Growth3 Y	2.56%
Net Income	THB 523.1M
Net Income Growth	16.06%
Net Income Growth Q	68.16%
Net Income Growth3 Y	3.45%
Pretax Margin	24.3%
Profit Margin	20.71%
Profit Per Employee	THB 554,096
ROA	10.1
Roa5y	11.56
ROCE	26.22
ROE	26.91
Roe5y	31.39
ROIC	21.85
Roic5y	23.42

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	17.75%
EPS Growth	-0.35
EPS Growth Q	63.14
EPS Growth3 Y	-11.59
FCF Growth	-68.18%
FCF Growth3 Y	-27.53%
OCF Growth	-35.26%
OCF Growth3 Y	-13.7%
Revenue Growth	13.48x
Revenue Growth Q	25.87x
Revenue Growth3 Y	7.65x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	THB 0.7
Assets	THB 3.8B
Cash	THB 751.6M
Current Assets	THB 2.4B
Current Liabilities	THB 1.6B
Debt	THB 943.5M
Debt EBITDA	THB 1.33
Debt Equity	THB 0.45
Debt FCF	THB 8.58
Equity	THB 2.1B
Interest Coverage	20.56
Liabilities	THB 1.7B
Long Term Assets	THB 1.4B
Long Term Liabilities	THB 113.4M
Net Cash	THB -191.8M
Net Cash By Market Cap	THB -4.06
Net Debt EBITDA	THB 0.27
Net Debt Equity	THB 0.09
Net Debt FCF	THB 1.74
Tangible Book Value	THB 2.1B
Tangible Book Value Per Share	THB 5.18

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.55
Inventory Turnover	2.32
Net Working Capital	THB 980.8M
Quick ratio	1.15
Working Capital	THB 852.2M
Working Capital Turnover	THB 4.09

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-16.47%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	THB 0.32
Dividend Years	2
Dividend Yield	2.71%
Ex Div Date	2026-05-08
Last Dividend	THB 0.32
Payout Frequency	Semi-Annual
Payout Ratio	33.63%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	17.74%
200-day SMA	11.62
50-day SMA	12.78
50-day SMA vs 200-day SMA	50over200
All Time High	19.3
All Time High Change	-38.86%
All Time High Date	2024-10-22
All Time Low	9.9
All Time Low Change	19.19%
All Time Low Date	2025-04-08
ATR	0.29
Beta1y	0.33
Beta2y	0.72
Ch YTD	14.56
High	12
High52	13.6
High52 Date	2026-02-26
High52ch	-13.24%
Low	11.8
Low52	9.95
Low52 Date	2025-11-24
Low52ch	18.59%
Ma50ch	-7.7%
Price vs 200-day SMA	1.55%
RSI	29.74
RSI Monthly	35.84
RSI Weekly	48.19
Sharpe ratio	0.61x
Sortino ratio	1.19
Total Return	-13.76%
Tr YTD	17.62
Tr1m	-6.81%
Tr1w	-6.08%
Tr3m	14.29%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	THB 584.8M
Operating Income Growth	6.33
Operating Income Growth Q	16.64
Operating Income Growth3 Y	-1.3
Operating margin	23.15

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	75,599,298%
Net Borrowing	-212,278,039
Shares Insiders	27.16%
Shares Institutions	0.52%
Shares Out	400,003,600
Shares Qo Q	-0.53%
Shares Yo Y	16.47%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	THB 110M
Average Volume	136,514.7x
Bv Per Share	5.29
CAPEX	THB -226.4M
Ch1m	-9.23
Ch1w	-8.53
Ch1y	12.38
Ch3m	11.32
Ch6m	15.69
Change	-1.5%
Change From Open	0
Close	11.98
Days Gap	-1.5
Depreciation Amortization	115,925,773
Dollar Volume	3,482,770
Earnings Date	2026-05-14
EBIT	THB 584.8M
EBITDA	THB 700.7M
EPS	THB 1.31
F Score	4
FCF	THB 110M
FCF EV Yield	2.24x
FCF Per Share	THB 0.27
Financing CF	-416,630,034
Fiscal Year End	December
Founded	1,991
Graham Number	12.4786
Graham Upside	5.75
Income Tax	THB 90.7M
Investing CF	131,118,193
Is Primary Listing	1
Last Earnings Date	2026-02-25
Last Report Date	2025-12-31
Lynch Fair Value	THB 6.54
Lynch Upside	-44.59
Ma150	11.47
Ma150ch	2.91%
Ma20	12.82
Ma20ch	-7.96%
Net CF	50,928,908
Next Earnings Date	2026-05-14
Open	11.8
P FCF Ratio	42.91
P OCF Ratio	14.03
Payment Date	2026-05-26
Position In Range	0
Ppne	1,204,120,873
Price Date	2026-05-08
Price EBITDA	THB 6.74
Ptbv Ratio	2.28
Relative Volume	2.16x
Revenue	2,526,065,912x
Tax By Revenue	3.59x
Tax Rate	14.78%
Tr6m	18.78%
Volume	295,150
Z Score	3.39

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BKK/TMAN dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.7%

$0.32 annual per share

Payout ratio

+33.6%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

-13.8%

Next ex-dividend date: 2026-05-08

Performance

BKK/TMAN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BKK/TMAN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.5%

Share of float held by funds and institutions

Insider ownership

+27.2%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+16.5%

Negative means the company is buying back shares.

Technical

BKK/TMAN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

29.7

Below 30: short-term oversold

Price vs 200-day MA

+1.5%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.61

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BKK/TMAN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bkk/TMAN stock rating?

bkk/TMAN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bkk/TMAN analysis?

The full report lives at /stocks/bkk/TMAN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bkk/TMAN?

The latest report frames bkk/TMAN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bkk/TMAN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.